对《偏头痛治疗：当前的急性药物及其潜在作用机制》的勘误
Correction to: Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.
作者信息
Ong Jonathan Jia Yuan, De Felice Milena
机构信息
Headache Group, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College, London, London, UK.
NIHR-Wellcome Trust King's Clinical Research Facility, Kings College Hospital, London, UK.
出版信息
Neurotherapeutics. 2018 Apr;15(2):525-526. doi: 10.1007/s13311-017-0599-7.
Abstract
This article was updated to correct an error in figure 1 introduced during the production process.
摘要
本文已更新，以纠正制作过程中在图1中出现的一处错误。
相似文献
1
Correction to: Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.对《偏头痛治疗：当前的急性药物及其潜在作用机制》的勘误
Neurotherapeutics. 2018 Apr;15(2):525-526. doi: 10.1007/s13311-017-0599-7.
2
Pharmacological synergy: the next frontier on therapeutic advancement for migraine.药物协同作用：偏头痛治疗进展的下一个前沿领域。
Headache. 2012 Apr;52(4):636-47. doi: 10.1111/j.1526-4610.2011.02058.x. Epub 2012 Jan 6.
3
Correction to: Hepatitis B virus perceptions and health seeking behaviors among pregnant women in Uganda: implications for prevention and policy.对《乌干达孕妇对乙肝病毒的认知及就医行为：对预防和政策的启示》的勘误
BMC Health Serv Res. 2019 Dec 20;19(1):982. doi: 10.1186/s12913-019-4767-9.
4
Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.偏头痛治疗：当前急性药物治疗及其潜在作用机制。
Neurotherapeutics. 2018 Apr;15(2):274-290. doi: 10.1007/s13311-017-0592-1.
5
Acute Migraine Treatment.急性偏头痛治疗。
Continuum (Minneap Minn). 2021 Jun 1;27(3):597-612. doi: 10.1212/CON.0000000000000956.
6
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).对以下内容的更正：加卡尼单抗治疗发作性偏头痛：3期研究（EVOLVE-1和EVOLVE-2）中偏头痛发作高频率与低频率的疗效亚组分析。
J Headache Pain. 2019 Dec 27;20(1):118. doi: 10.1186/s10194-019-1069-x.
7
The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.成人偏头痛的急性治疗：美国头痛协会对偏头痛药物疗法的证据评估
Headache. 2015 Jan;55(1):3-20. doi: 10.1111/head.12499.
8
Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway.新型急性偏头痛特异性药物（nAMSMs）在靶向降钙素基因相关肽（CGRP）通路单克隆抗体（mAbs）背景下起始治疗的患者治疗模式。
J Headache Pain. 2023 Nov 9;24(1):153. doi: 10.1186/s10194-023-01678-y.
9
Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study.用于预测非处方急性偏头痛药物治疗反应的预测模型：来自美国偏头痛患病率和预防研究的结果。
Headache. 2022 Jun;62(6):755-765. doi: 10.1111/head.14312. Epub 2022 May 11.
10
Beta-Blockers for Migraine Prevention: a Review Article.用于预防偏头痛的β受体阻滞剂：一篇综述文章。
Curr Treat Options Neurol. 2019 Mar 23;21(4):20. doi: 10.1007/s11940-019-0556-3.
引用本文的文献
1
Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment.双相情感障碍与偏头痛共病：从机制到治疗
Front Psychiatry. 2021 Jan 11;11:560138. doi: 10.3389/fpsyt.2020.560138. eCollection 2020.
2
Acid-sensing ion channel 3 blockade inhibits durovascular and nitric oxide-mediated trigeminal pain.酸敏感离子通道3阻断可抑制硬脑膜血管及一氧化氮介导的三叉神经痛。
Br J Pharmacol. 2020 Jun;177(11):2478-2486. doi: 10.1111/bph.14990. Epub 2020 Mar 2.
3
Mitochondrial Migraine: Disentangling the angiopathy paradigm in m.3243A>G patients.线粒体偏头痛：解析m.3243A>G患者的血管病变模式
JIMD Rep. 2019 Mar 14;46(1):52-62. doi: 10.1002/jmd2.12017. eCollection 2019 Mar.
Zotero 插件